Cytokinetics Inc (CYTK)

Cytokinetics Inc Stock (CYTK) Forecast

The Cytokinetics Inc (CYTK) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $55.31, representing a -1.47% decrease from the current price of $56.13. The highest analyst price target is $60.81, and the lowest is $49.81.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month CYTK Price Target

Average 58.39 (+4.02% Downside)

Is Cytokinetics Inc (CYTK) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	38.17	Neutral
STOCH(9,6)	21.22	Neutral
STOCHRSI(14)	49.62	Neutral
MACD(12,26)	-2.32	Sell
ADX(14)	25.74	Sell
William %R	-77.39	Neutral
CCI(14)	-85.32	Neutral

Buy: 0 · Sell: 2 · Neutral: 5Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	57.93 Sell	57.73 Sell
MA20	60.11 Sell	59.51 Sell
MA50	64.11 Sell	63.73 Sell
MA100	71.73 Sell	67.22 Sell
MA200	69.78 Sell	66.72 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, CYTK could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CYTK, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 38.17 indicates that CYTK is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 21.22 indicates that CYTK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 49.62 indicates that CYTK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 25.74 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
CCI (Commodity Channel Index): A CCI(14) value of -85.32 indicates that CYTK is still oversold but not to an extreme extent.

Long-term CYTK price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Cytokinetics Inc financial reports and earnings history, Cytokinetics Inc (CYTK) stock could reach $78.10 by 2030, $163.49 by 2040 and $136.98 by 2050. See the projected annual prices until 2050 of the Cytokinetics Inc stock below:

Cytokinetics Inc (CYTK) is expected to reach an average price of $88.50 in 2035, with a high prediction of $122.16 and a low estimate of $82.63. This indicates an +57.67% change from the last recorded price of $56.13.
Cytokinetics Inc (CYTK) stock is projected to chart a bullish course in 2040, with an average price target of $119.61, representing an +113.10% change from its current level. The forecast ranges from a conservative $78.29 to a sky-high $163.49.
Our analysts predict Cytokinetics Inc (CYTK) to change +78.77% by 2045, soaring from $95.73 to an average price of $100.35, potentially reaching $113.68. While $95.73 is the low estimate, the potential upside is significant.
Cytokinetics Inc (CYTK) stock is expected to climb by 2050, reaching an average of $125.84, a +124.20% change from its current level. However, a wide range of estimates exists, with high and low targets of $136.98 and $112.56, respectively, highlighting the market's uncertainty.

Cytokinetics Inc Stock (CYTK) Year by Year Forecast

Cytokinetics Inc Stock (CYTK) Price Forecast for 2026

The predicted value for Cytokinetics Inc (CYTK) in 2026 is set at an average of $67.41. Estimates vary from a peak of $88.31 to a trough of $49.81, indicating an +20.09% surge from the present price of $56.13.

Month	Average	Low	High	Change from today's price
December, 2026	$60.05	$49.81	$60.81	+6.98%

Cytokinetics Inc Stock (CYTK) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Cytokinetics Inc (CYTK) is $57.54, with a high forecast of $72.03 and a low forecast of $44.74. This indicates an +2.52% increase from the last price of $56.13.

Month	Average	Low	High	Change from today's price
January, 2027	$45.76	$45.39	$63.31	-18.47%
February, 2027	$55.86	$44.74	$56.45	-0.48%
March, 2027	$53.14	$45.85	$56.58	-5.33%
April, 2027	$54.09	$48.76	$54.36	-3.63%
May, 2027	$53.87	$49.39	$59.26	-4.02%
June, 2027	$55.79	$50.33	$60.70	-0.61%
July, 2027	$63.22	$53.76	$64.07	+12.62%
August, 2027	$54.80	$54.22	$65.40	-2.36%
September, 2027	$66.82	$54.43	$70.86	+19.05%
October, 2027	$70.74	$64.24	$72.02	+26.03%
November, 2027	$62.26	$62.21	$72.03	+10.93%
December, 2027	$54.14	$52.77	$65.99	-3.54%

Cytokinetics Inc Stock (CYTK) Price Forecast for 2028

In 2028, Cytokinetics Inc (CYTK) is projected to reach an average price of $54.87, with a high projection of $64.04 and a low estimate of $47.90. This indicates an -2.25% fall from the last price of $56.13.

Month	Average	Low	High	Change from today's price
January, 2028	$56.98	$52.08	$59.18	+1.51%
February, 2028	$62.39	$51.86	$64.04	+11.15%
March, 2028	$59.76	$56.78	$62.81	+6.47%
April, 2028	$62.43	$57.51	$62.56	+11.23%
May, 2028	$52.15	$51.19	$62.24	-7.10%
June, 2028	$51.67	$49.80	$54.93	-7.94%
July, 2028	$55.97	$51.65	$57.92	-0.28%
August, 2028	$54.13	$53.76	$58.25	-3.56%
September, 2028	$51.86	$49.41	$54.96	-7.61%
October, 2028	$50.43	$47.90	$53.42	-10.15%
November, 2028	$52.26	$48.26	$53.40	-6.89%
December, 2028	$48.35	$47.99	$54.46	-13.86%

Cytokinetics Inc Stock (CYTK) Price Forecast for 2029

The 2029 price forecast for Cytokinetics Inc Stock (CYTK) is $76.23 on average, with a high prediction of $128.00 and a low estimate of $43.42. This represents an +35.82% increase from the previous price of $56.13.

Month	Average	Low	High	Change from today's price
January, 2029	$49.23	$43.42	$53.64	-12.28%
February, 2029	$50.01	$48.60	$54.31	-10.90%
March, 2029	$51.75	$48.29	$53.28	-7.80%
April, 2029	$103.35	$50.39	$128.00	+84.12%
May, 2029	$99.69	$95.07	$104.40	+77.61%
June, 2029	$90.14	$87.31	$99.26	+60.59%
July, 2029	$88.11	$79.29	$92.95	+56.97%
August, 2029	$83.41	$81.97	$93.75	+48.61%
September, 2029	$77.68	$74.06	$86.57	+38.40%
October, 2029	$71.77	$64.44	$79.57	+27.86%
November, 2029	$74.74	$69.08	$77.18	+33.15%
December, 2029	$74.92	$69.45	$79.73	+33.48%

Cytokinetics Inc Stock (CYTK) Price Forecast for 2030

Cytokinetics Inc Stock (CYTK) is expected to reach an average price of $64.15 in 2030, with a high forecast of $78.10 and a low forecast of $48.58. This signifies an +14.29% surge from the last price of $56.13.

Month	Average	Low	High	Change from today's price
January, 2030	$74.38	$71.35	$77.14	+32.51%
February, 2030	$75.26	$70.01	$76.28	+34.08%
March, 2030	$69.66	$69.19	$75.58	+24.10%
April, 2030	$70.61	$66.14	$78.10	+25.80%
May, 2030	$66.19	$64.47	$70.75	+17.92%
June, 2030	$64.65	$63.40	$69.02	+15.17%
July, 2030	$69.26	$59.51	$71.75	+23.40%
August, 2030	$64.51	$61.10	$70.00	+14.93%
September, 2030	$58.66	$51.90	$67.53	+4.50%
October, 2030	$50.95	$50.92	$62.73	-9.23%
November, 2030	$51.63	$48.58	$52.64	-8.01%
December, 2030	$54.09	$51.38	$54.52	-3.64%